Nexus

Multi Cellular Assay

  • Bi-culture
  • Tri-culture
  • Proteomics
  • Blood Brain Barrier

Assays

The Platform

Built on Olink proximity extension assay technology

Multiplexed, high-sensitivity protein quantification from just 1 µL of sample, across a broad dynamic range.Reported as Normalised Protein eXpression (NPX) on a log₂ scale.

Five core primary cell disease models:

  • Inflammation
  • Autoimmunity
  • Oncology Fibrosis
  • Neuroinflammation
40

immune analytes per panel

5

core human disease models

1
µL

sample volume required

Olink

PEA quantification platform

ioGlut (SNCA A53T/A53T) neuron and ioMicroglia co-cultures in the presence/absence of alpha-synuclein (aSyn) A53T for 7 days. ioGlut neurons were cultured for 7 days before treatment with/without αSyn bearing A53T mutation. ioMicroglia are added on Day 8 as according to manufacturer’s instructions and co-cultured with ioGlut for 4 days. On day 12, cells were fixed for immunofluorescence staining and imaged on the OperaPhenix at 10x. The immunofluorescence panel included IBA1 (microglia marker), αSyn (total), pS129-αSyn (aggregated form) and Thioflavin (Th-T) staining for protein aggregation. Scale bar 100 μm.

Cellular uptake of α-syn. PD-relevant ioGlut neurons (A53T SNCA) were cultured for 7 days without exogenous α-synuclein. On day 7 α-syn preformed fibrils were added to neurons for 12 days. On Day 19 neurons were stained with pHrodo-labelled anti-total α-syn for 1 hour prior to microglia addition. ioMicroglia were then added to neuronal cultures as according to manufacturer’s instructions. Co-cultures were left untreated (media), treated with DMSO vehicle control or with cytochalasin D (Cyto D) and imaged using Opera Phenix Imaging system.

Drug Discovery Tool

Find the right immune assay for your therapeutic area, modality and target using this interactive Drug Discovery Tool.

Explore now
Speak to a Scientist

Learn how the Nexus BioQuest team can help with your pre-clinical drug discovery programs.

Schedule a call